Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients

Francesca Mallamaci, Carmine Zoccali, Saverio Parlongo, Giovanni Tripepi, Francesco A. Benedetto, Sebastiano Cutrupi, Graziella Bonanno, Pasquale Fatuzzo, Francesco Rapisarda, Giuseppe Seminara, Benedetta Stancanelli, Ignazio Bellanuova, Alessando Cataliotti, Lorenzo S. Malatino

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Cardiac troponin T (cTnT) predicts death and cardiovascular outcomes in clinically stable patients with end-stage renal disease. Because this protein is synthesized exclusively in myocardial cells, its predictive power for these outcomes may be because it reflects, besides cardiac ischemia, left ventricular (LV) mass, which is a strong predictor of cardiovascular death in this population per se. We tested the relationship between cTnT level and LV mass and the predictive power of this cardiac protein for all-cause and cardiovascular mortality in a cohort of hemodialysis patients (n = 199) without acute coronary syndrome and heart failure followed up for an average of 35 months (range, 0.8 to 52 months). cTnT was measured by means of a third-generation electrochemiluminescence immunoassay. cTnT level was related directly to interventricular septum (r = 0.36; P < 0.001) and posterior wall thickness (r = 0.40; P < 0.001), as well as LV mass (r = 0.45; P < 0.001). On multivariate analysis, after age, LV mass was the strongest independent predictor of cTnT level (β = 0.28; P < 0.001). Serum cTnT level was significantly related to all-cause and cardiovascular mortality on univariate analysis (P < 0.001). On multivariate Cox regression analysis, the adjusted risk for all-cause death was 2.39 times (95% confidence interval [CI], 1.13 to 5.06; P = 0.02) greater in patients in the third cTnT tertile than the first tertile, and a similar pattern emerged for cardiovascular mortality (hazard ratio, 2.35; 95% CI, 1.01 to 5.49; P = 0.048). In hemodialysis patients, plasma cTnT level is independently related to LV mass and predicts all-cause and cardiovascular mortality. These data support the hypothesis that this marker can be usefully applied for risk stratification in clinically stable dialysis patients.

Original languageEnglish (US)
Pages (from-to)68-75
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume40
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Troponin T
Troponin
Renal Dialysis
Mortality
Confidence Intervals
Acute Coronary Syndrome
Immunoassay
Chronic Kidney Failure
Dialysis
Cause of Death
Proteins
Multivariate Analysis
Ischemia
Heart Failure
Regression Analysis
Serum

Keywords

  • Cardiovascular risk
  • Dialysis
  • Ischemia
  • Left ventricular hypertrophy (LVH)
  • Survival
  • Troponin

ASJC Scopus subject areas

  • Nephrology

Cite this

Mallamaci, F., Zoccali, C., Parlongo, S., Tripepi, G., Benedetto, F. A., Cutrupi, S., ... Malatino, L. S. (2002). Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. American Journal of Kidney Diseases, 40(1), 68-75. https://doi.org/10.1053/ajkd.2002.33914

Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. / Mallamaci, Francesca; Zoccali, Carmine; Parlongo, Saverio; Tripepi, Giovanni; Benedetto, Francesco A.; Cutrupi, Sebastiano; Bonanno, Graziella; Fatuzzo, Pasquale; Rapisarda, Francesco; Seminara, Giuseppe; Stancanelli, Benedetta; Bellanuova, Ignazio; Cataliotti, Alessando; Malatino, Lorenzo S.

In: American Journal of Kidney Diseases, Vol. 40, No. 1, 2002, p. 68-75.

Research output: Contribution to journalArticle

Mallamaci, F, Zoccali, C, Parlongo, S, Tripepi, G, Benedetto, FA, Cutrupi, S, Bonanno, G, Fatuzzo, P, Rapisarda, F, Seminara, G, Stancanelli, B, Bellanuova, I, Cataliotti, A & Malatino, LS 2002, 'Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients', American Journal of Kidney Diseases, vol. 40, no. 1, pp. 68-75. https://doi.org/10.1053/ajkd.2002.33914
Mallamaci, Francesca ; Zoccali, Carmine ; Parlongo, Saverio ; Tripepi, Giovanni ; Benedetto, Francesco A. ; Cutrupi, Sebastiano ; Bonanno, Graziella ; Fatuzzo, Pasquale ; Rapisarda, Francesco ; Seminara, Giuseppe ; Stancanelli, Benedetta ; Bellanuova, Ignazio ; Cataliotti, Alessando ; Malatino, Lorenzo S. / Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. In: American Journal of Kidney Diseases. 2002 ; Vol. 40, No. 1. pp. 68-75.
@article{bbe3ada8273e4452b9a15990f0905466,
title = "Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients",
abstract = "Cardiac troponin T (cTnT) predicts death and cardiovascular outcomes in clinically stable patients with end-stage renal disease. Because this protein is synthesized exclusively in myocardial cells, its predictive power for these outcomes may be because it reflects, besides cardiac ischemia, left ventricular (LV) mass, which is a strong predictor of cardiovascular death in this population per se. We tested the relationship between cTnT level and LV mass and the predictive power of this cardiac protein for all-cause and cardiovascular mortality in a cohort of hemodialysis patients (n = 199) without acute coronary syndrome and heart failure followed up for an average of 35 months (range, 0.8 to 52 months). cTnT was measured by means of a third-generation electrochemiluminescence immunoassay. cTnT level was related directly to interventricular septum (r = 0.36; P < 0.001) and posterior wall thickness (r = 0.40; P < 0.001), as well as LV mass (r = 0.45; P < 0.001). On multivariate analysis, after age, LV mass was the strongest independent predictor of cTnT level (β = 0.28; P < 0.001). Serum cTnT level was significantly related to all-cause and cardiovascular mortality on univariate analysis (P < 0.001). On multivariate Cox regression analysis, the adjusted risk for all-cause death was 2.39 times (95{\%} confidence interval [CI], 1.13 to 5.06; P = 0.02) greater in patients in the third cTnT tertile than the first tertile, and a similar pattern emerged for cardiovascular mortality (hazard ratio, 2.35; 95{\%} CI, 1.01 to 5.49; P = 0.048). In hemodialysis patients, plasma cTnT level is independently related to LV mass and predicts all-cause and cardiovascular mortality. These data support the hypothesis that this marker can be usefully applied for risk stratification in clinically stable dialysis patients.",
keywords = "Cardiovascular risk, Dialysis, Ischemia, Left ventricular hypertrophy (LVH), Survival, Troponin",
author = "Francesca Mallamaci and Carmine Zoccali and Saverio Parlongo and Giovanni Tripepi and Benedetto, {Francesco A.} and Sebastiano Cutrupi and Graziella Bonanno and Pasquale Fatuzzo and Francesco Rapisarda and Giuseppe Seminara and Benedetta Stancanelli and Ignazio Bellanuova and Alessando Cataliotti and Malatino, {Lorenzo S.}",
year = "2002",
doi = "10.1053/ajkd.2002.33914",
language = "English (US)",
volume = "40",
pages = "68--75",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients

AU - Mallamaci, Francesca

AU - Zoccali, Carmine

AU - Parlongo, Saverio

AU - Tripepi, Giovanni

AU - Benedetto, Francesco A.

AU - Cutrupi, Sebastiano

AU - Bonanno, Graziella

AU - Fatuzzo, Pasquale

AU - Rapisarda, Francesco

AU - Seminara, Giuseppe

AU - Stancanelli, Benedetta

AU - Bellanuova, Ignazio

AU - Cataliotti, Alessando

AU - Malatino, Lorenzo S.

PY - 2002

Y1 - 2002

N2 - Cardiac troponin T (cTnT) predicts death and cardiovascular outcomes in clinically stable patients with end-stage renal disease. Because this protein is synthesized exclusively in myocardial cells, its predictive power for these outcomes may be because it reflects, besides cardiac ischemia, left ventricular (LV) mass, which is a strong predictor of cardiovascular death in this population per se. We tested the relationship between cTnT level and LV mass and the predictive power of this cardiac protein for all-cause and cardiovascular mortality in a cohort of hemodialysis patients (n = 199) without acute coronary syndrome and heart failure followed up for an average of 35 months (range, 0.8 to 52 months). cTnT was measured by means of a third-generation electrochemiluminescence immunoassay. cTnT level was related directly to interventricular septum (r = 0.36; P < 0.001) and posterior wall thickness (r = 0.40; P < 0.001), as well as LV mass (r = 0.45; P < 0.001). On multivariate analysis, after age, LV mass was the strongest independent predictor of cTnT level (β = 0.28; P < 0.001). Serum cTnT level was significantly related to all-cause and cardiovascular mortality on univariate analysis (P < 0.001). On multivariate Cox regression analysis, the adjusted risk for all-cause death was 2.39 times (95% confidence interval [CI], 1.13 to 5.06; P = 0.02) greater in patients in the third cTnT tertile than the first tertile, and a similar pattern emerged for cardiovascular mortality (hazard ratio, 2.35; 95% CI, 1.01 to 5.49; P = 0.048). In hemodialysis patients, plasma cTnT level is independently related to LV mass and predicts all-cause and cardiovascular mortality. These data support the hypothesis that this marker can be usefully applied for risk stratification in clinically stable dialysis patients.

AB - Cardiac troponin T (cTnT) predicts death and cardiovascular outcomes in clinically stable patients with end-stage renal disease. Because this protein is synthesized exclusively in myocardial cells, its predictive power for these outcomes may be because it reflects, besides cardiac ischemia, left ventricular (LV) mass, which is a strong predictor of cardiovascular death in this population per se. We tested the relationship between cTnT level and LV mass and the predictive power of this cardiac protein for all-cause and cardiovascular mortality in a cohort of hemodialysis patients (n = 199) without acute coronary syndrome and heart failure followed up for an average of 35 months (range, 0.8 to 52 months). cTnT was measured by means of a third-generation electrochemiluminescence immunoassay. cTnT level was related directly to interventricular septum (r = 0.36; P < 0.001) and posterior wall thickness (r = 0.40; P < 0.001), as well as LV mass (r = 0.45; P < 0.001). On multivariate analysis, after age, LV mass was the strongest independent predictor of cTnT level (β = 0.28; P < 0.001). Serum cTnT level was significantly related to all-cause and cardiovascular mortality on univariate analysis (P < 0.001). On multivariate Cox regression analysis, the adjusted risk for all-cause death was 2.39 times (95% confidence interval [CI], 1.13 to 5.06; P = 0.02) greater in patients in the third cTnT tertile than the first tertile, and a similar pattern emerged for cardiovascular mortality (hazard ratio, 2.35; 95% CI, 1.01 to 5.49; P = 0.048). In hemodialysis patients, plasma cTnT level is independently related to LV mass and predicts all-cause and cardiovascular mortality. These data support the hypothesis that this marker can be usefully applied for risk stratification in clinically stable dialysis patients.

KW - Cardiovascular risk

KW - Dialysis

KW - Ischemia

KW - Left ventricular hypertrophy (LVH)

KW - Survival

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=0036286283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036286283&partnerID=8YFLogxK

U2 - 10.1053/ajkd.2002.33914

DO - 10.1053/ajkd.2002.33914

M3 - Article

C2 - 12087563

AN - SCOPUS:0036286283

VL - 40

SP - 68

EP - 75

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -